Key indicatorsSingle-crystal X-ray study T = 293 K Mean '(C±C) = 0.004 A Ê R factor = 0.061 wR factor = 0.122 Data-to-parameter ratio = 14.5For details of how these key indicators were automatically derived from the article, see
Various polyfluoro-cyclic olefins have been treated with several alcohols in the presence of a base, and the ethers formed fully characterised. Each reaction, with one exception, gave two mono-alkoxy-olefins, one substituted in the vinylic position, the other in the allylic positioc, by what appears to be an addition-elimination pathway; the ratio of these ethers varied with the alcohol and olefin used. I n the characterisation of these olefinic ethers, potassium permanganate oxidation gave a number of new alkoxypolyfluorodibasic acids.View Article Online centred a t 4.5 (intensity ratio 1).Reaction of 2,2,3,3-TetrafEuoropropan-l-ol with Decafluorocyc1ohexene.-In the usual way (E 2.67 x lo3) (in ethanol).
The title compound, C10H8O2S2, is the 3‐thienyl symmetric analog of benzoin. 3,3′‐Thenoin can be synthesized in good yield utilizing the benzoin condensation reaction (starting with 3‐thiophenecarboxaldehyde). The crystal structure of 3,3′‐thenoin has been determined at room temperature. There are two independent molecules per asymmetric unit and each has a thienyl ring flip disorder involving one of the two rings in each molecule.
The title compound, C10H8O2S2, is the 2‐thienyl symmetric analog of benzoin. 2,2′–Thenoin can be synthesized in good yield utilizing the benzoin condensation reaction (starting with 2‐thiophenecarboxaldehyde). The crystal structure of 2,2′‐thenoin has been determined at room temperature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.